Fu-Nan Liu
Overview
Explore the profile of Fu-Nan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruan D, Liu F, Wei X, Luo S, Zhuang Z, Wang Z, et al.
Lancet Oncol
. 2025 Jan;
26(2):227-238.
PMID: 39788133
Background: CMG901 is a novel first-in-class antibody-drug conjugate with a humanised anticlaudin 18.2 antibody linked to microtubule-disrupting agent monomethyl auristatin E. We aimed to assess the antitumour activity and safety...
2.
Pan S, Wang P, Huang H, Luo L, Wang X, Wang T, et al.
Gastroenterol Res Pract
. 2019 Feb;
2019:3248727.
PMID: 30804994
Background: In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer...
3.
Lai S, Chen J, Huang H, Zhang X, Jiang H, Li W, et al.
Oncol Rep
. 2018 Jul;
40(3):1650-1656.
PMID: 30015973
Vascular endothelial growth factor receptor 2 (VEGFR2) and c‑Met are tyrosine kinases, which are involved in the tumorigenesis of various types of cancer. Previous studies have demonstrated that the elevated...
4.
Wang P, Huang J, Zhu Z, Gong B, Huang H, Duan S, et al.
Eur J Surg Oncol
. 2018 Feb;
44(5):600-606.
PMID: 29454557
Background: The status of serosal invasion is often discordance between pathological and intraoperative evaluation. Our study sought to develop a risk-scoring system (RSS) to predict the probability of pT4a for...
5.
Duan S, Gao Z, Wang P, Gong B, Huang H, Luo L, et al.
Medicine (Baltimore)
. 2018 Feb;
96(51):e9391.
PMID: 29390545
Rationale: cetuximab, an epidermal growth factor receptor inhibitor, is a targeted therapeutic regimen of colorectal cancers. Several common adverse effects have been found, such as cutaneous or gastrointestinal toxicity. However,...
6.
Wang P, Xiao F, Gong B, Liu F
Oncotarget
. 2017 Dec;
8(58):99013-99023.
PMID: 29228746
Background: Many studies investigated the association between alcohol drinking and gastric cancer risk, but the results were controversial. We performed a meta-analysis of observational studies to explore the association. Materials...
7.
Huang H, Zhang X, Song P, Jiang H, Li W, Wang P, et al.
Biochem Biophys Res Commun
. 2017 Nov;
495(1):728-732.
PMID: 29146188
This paper describes the identification of chlorhexidine, an agent commonly used in clinical as a novel potential allosteric inhibitor of PAK1. In cellular assays, chlorhexidine showed a good inhibitory profile,...
8.
Wang P, Xiao F, Gong B, Liu F, Xu H
J Gastrointest Surg
. 2017 Mar;
21(6):947-956.
PMID: 28349332
Insufficient number of examined lymph nodes (eLNs) was considered to increase significantly the risk of stage migration in gastric cancer patients. The aim of our study is to establish a...
9.
Na D, Lv Z, Liu F, Xu Y, Jiang C, Sun Z, et al.
BMC Gastroenterol
. 2012 Apr;
12:34.
PMID: 22520554
Background: In this study, we examined effects of soluble factors released by gastric cancer cells on peritoneal mesothelial cells in vitro and in vivo. Methods: HMrSV5, a human peritoneal mesothelial...
10.
Sun Z, Wang Z, Xu Y, Zhu G, Huang B, Xu Y, et al.
Surgery
. 2012 Mar;
151(6):871-81.
PMID: 22386276
Background: To investigate the prognostic significance of tumor deposits (TDs) in gastric cancers patients who underwent radical surgery. Methods: Clinicopathologic and prognostic data from 2998 gastric cancer patients who underwent...